Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of <i>Enterobacterales</i> (<i>Enterobacteriaceae</i>) and <i>Pseudomonas aeruginosa</i> to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods

Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of <i>Enterobacterales</i> (<i>Enterobacteriaceae</i>) and <i>Pseudomonas aeruginosa</i> to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods

This study aimed to assess the comparability of in vitro susceptibility testing methods to ceftazidime-avibactam (CZA) and ceftolozane-tazobactam (C/T). Meropenem-resistant and/or carbapenemase-producing clinical isolates of <i>Enterobacterales</i> (<i>Enterobacteriaceae</i>)...

Full description

Bibliographic Details
Main Authors: Venere Cortazzo, Brunella Posteraro, Giulia Menchinelli, Flora Marzia Liotti, Tiziana D’Inzeo, Barbara Fiori, Francesco Luzzaro, Maurizio Sanguinetti, Teresa Spanu
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Antibiotics
Subjects:
susceptibility testing
ceftazidime-avibactam
ceftolozane-tazobactam
VITEK 2
ETEST
broth microdilution method
Online Access:https://www.mdpi.com/2079-6382/11/8/1023

Internet

https://www.mdpi.com/2079-6382/11/8/1023

Similar Items